Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays
Open Access
- 11 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9) , e44824
- https://doi.org/10.1371/journal.pone.0044824
Abstract
Systemic lupus erythematosus is characterized by dysfunctional clearance of apoptotic debris and the development of pathogenic autoantibodies. While the complement system is also involved in the disease no attempt has been made to generate a comprehensive view of immune complex formation from various autoantigens. We increased the complexity of autoantibody profiles by measuring the binding of two complement proteins, C3 and C4, in addition to two antibody classes, IgG and IgM, to a collection of autoantigens. These complement components covalently bind to those microarray features where antibodies and other serum components induce complement activation. Using this technology, we compared functional serum antibody profiles of control subjects (n = 31) and patients with lupus erythematosus (n = 61) in the active (n = 22) and inactive (n = 39) phase of the disease. Multivariate analysis was applied to identify contributions of binding data on 25 antigens to the discrimination of the study groups. Receiver operating characteristic analysis was used to portray the discriminative property of each measured parameter for each antigen in pairwise group comparisons. Complement C3 and C4 deposition increased on autoantibody targets in spite of the decreased serum complement concentrations, and decreased on other autoantigens, demonstrating the imbalance of complement function in patients with lupus erythematosus. Our observations confirmed previously known markers of disease and showed that C3 and C4 deposition data were at least as powerful as Ig binding data in separating the study groups.Keywords
This publication has 29 references indexed in Scilit:
- Anti‐C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: A controlled study of 126 consecutive patientsArthritis & Rheumatism, 2011
- Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr miceRheumatology, 2010
- An antibody profile of systemic lupus erythematosus detected by antigen microarrayImmunology, 2010
- The search for lupus biomarkersBest Practice & Research Clinical Rheumatology, 2009
- Lymphocyte‐Bound Complement Activation Products as Biomarkers for Diagnosis of Systemic Lupus ErythematosusClinical and Translational Science, 2009
- On-chip Complement Activation Adds an Extra Dimension to Antigen MicroarraysMolecular & Cellular Proteomics, 2007
- Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromesClinical and Experimental Immunology, 2006
- Complement and its breakdown products in SLERheumatology, 2005
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Complement activation by antibodies to DNA in systemic lupus erythematosus measured by enzyme immunoassayClinical Immunology and Immunopathology, 1985